Christopher E Barbieri1, Mark A Rubin. 1. aDepartment of Urology bDepartment of Pathology and Laboratory Medicine cSandra and Edward Meyer Cancer Center dInstitute for Precision Medicine, Weill Cornell Medical College, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: Genomic instability is a fundamental feature of human cancer, leading to the activation of oncogenes and inactivation of tumor suppressors. In prostate cancer (PCA), structural genomic rearrangements, resulting in gene fusions, amplifications, and deletions, are a critical mechanism effecting these alterations. Here, we review recent literature regarding the importance of genomic rearrangements in the pathogenesis of PCA and the potential impact on patient care. RECENT FINDINGS: Next-generation sequencing has revealed a striking abundance, complexity, and heterogeneity of genomic rearrangements in PCA. These recent studies have nominated a number of processes in predisposing PCA to genomic rearrangements, including androgen-induced transcription. SUMMARY: Structural rearrangements are the critical mechanism resulting in the characteristic genomic changes associated with PCA pathogenesis and progression. Future studies will determine whether the impact of these events on tumor phenotypes can be translated to clinical utility for patient prognosis and choices of management strategies.
PURPOSE OF REVIEW: Genomic instability is a fundamental feature of humancancer, leading to the activation of oncogenes and inactivation of tumor suppressors. In prostate cancer (PCA), structural genomic rearrangements, resulting in gene fusions, amplifications, and deletions, are a critical mechanism effecting these alterations. Here, we review recent literature regarding the importance of genomic rearrangements in the pathogenesis of PCA and the potential impact on patient care. RECENT FINDINGS: Next-generation sequencing has revealed a striking abundance, complexity, and heterogeneity of genomic rearrangements in PCA. These recent studies have nominated a number of processes in predisposing PCA to genomic rearrangements, including androgen-induced transcription. SUMMARY: Structural rearrangements are the critical mechanism resulting in the characteristic genomic changes associated with PCA pathogenesis and progression. Future studies will determine whether the impact of these events on tumor phenotypes can be translated to clinical utility for patient prognosis and choices of management strategies.
Authors: Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan Journal: Science Date: 2005-10-28 Impact factor: 47.728
Authors: Sven Perner; Francesca Demichelis; Rameen Beroukhim; Folke H Schmidt; Juan-Miguel Mosquera; Sunita Setlur; Joelle Tchinda; Scott A Tomlins; Matthias D Hofer; Kenneth G Pienta; Rainer Kuefer; Robert Vessella; Xiao-Wei Sun; Matthew Meyerson; Charles Lee; William R Sellers; Arul M Chinnaiyan; Mark A Rubin Journal: Cancer Res Date: 2006-09-01 Impact factor: 12.701
Authors: F Demichelis; K Fall; S Perner; O Andrén; F Schmidt; S R Setlur; Y Hoshida; J-M Mosquera; Y Pawitan; C Lee; H-O Adami; L A Mucci; P W Kantoff; S-O Andersson; A M Chinnaiyan; J-E Johansson; M A Rubin Journal: Oncogene Date: 2007-01-22 Impact factor: 9.867
Authors: Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Lisa R Smith; Diane Roulston; Beth E Helgeson; Xuhong Cao; John T Wei; Mark A Rubin; Rajal B Shah; Arul M Chinnaiyan Journal: Cancer Res Date: 2006-04-01 Impact factor: 12.701
Authors: David S Rickman; Dorothee Pflueger; Benjamin Moss; Vanessa E VanDoren; Chen X Chen; Alexandre de la Taille; Rainer Kuefer; Ashutosh K Tewari; Sunita R Setlur; Francesca Demichelis; Mark A Rubin Journal: Cancer Res Date: 2009-03-17 Impact factor: 12.701
Authors: Scott A Tomlins; Bharathi Laxman; Sooryanarayana Varambally; Xuhong Cao; Jindan Yu; Beth E Helgeson; Qi Cao; John R Prensner; Mark A Rubin; Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan Journal: Neoplasia Date: 2008-02 Impact factor: 5.715
Authors: Beth E Helgeson; Scott A Tomlins; Nameeta Shah; Bharathi Laxman; Qi Cao; John R Prensner; Xuhong Cao; Nirmish Singla; James E Montie; Sooryanarayana Varambally; Rohit Mehra; Arul M Chinnaiyan Journal: Cancer Res Date: 2008-01-01 Impact factor: 12.701
Authors: Olga Klezovitch; Michael Risk; Ilsa Coleman; Jared M Lucas; Manda Null; Lawrence D True; Peter S Nelson; Valeri Vasioukhin Journal: Proc Natl Acad Sci U S A Date: 2008-02-01 Impact factor: 11.205
Authors: Cameron S Osborne; Lyubomira Chakalova; Karen E Brown; David Carter; Alice Horton; Emmanuel Debrand; Beatriz Goyenechea; Jennifer A Mitchell; Susana Lopes; Wolf Reik; Peter Fraser Journal: Nat Genet Date: 2004-09-07 Impact factor: 38.330
Authors: Jennifer C King; Jin Xu; John Wongvipat; Haley Hieronymus; Brett S Carver; David H Leung; Barry S Taylor; Chris Sander; Robert D Cardiff; Suzana S Couto; William L Gerald; Charles L Sawyers Journal: Nat Genet Date: 2009-04-26 Impact factor: 38.330
Authors: Jennifer Cullen; Denise Young; Yongmei Chen; Michael Degon; James Farrell; Jason Sedarsky; Wagner Baptiste; Philip Rosen; Vladimir Tolstikov; Michael Kiebish; Jacob Kagan; Sudhir Srivastava; Huai-Ching Kuo; Joel T Moncur; Inger L Rosner; Niven Narain; Viatcheslav Akmaev; Gyorgy Petrovics; Albert Dobi; David G McLeod; Shiv Srivastava; Isabell A Sesterhenn Journal: Eur Urol Focus Date: 2017-03-11
Authors: Jennifer L Kalina; David S Neilson; Yen-Yi Lin; Phineas T Hamilton; Alexandra P Comber; Emma M H Loy; S Cenk Sahinalp; Colin C Collins; Faraz Hach; Julian J Lum Journal: Clin Cancer Res Date: 2017-09-27 Impact factor: 12.531
Authors: Ahmed A Mohamed; Shyh-Han Tan; Charles P Xavier; Shilpa Katta; Wei Huang; Lakshmi Ravindranath; Muhammad Jamal; Hua Li; Meera Srivastava; Eri S Srivatsan; Taduru L Sreenath; David G McLeod; Alagarsamy Srinivasan; Gyorgy Petrovics; Albert Dobi; Shiv Srivastava Journal: Mol Cancer Res Date: 2017-06-12 Impact factor: 5.852